Menu Search
Equities

All Cosmos Bio-Tech Holding Corp

4148:TAI

All Cosmos Bio-Tech Holding Corp

Actions
Basic MaterialsChemicals
  • Price (TWD)55.30
  • Today's Change1.80 / 3.36%
  • Shares traded210.33k
  • 1 Year change+38.77%
  • Beta--
Data delayed at least 20 minutes, as of Nov 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in TWDIncome statement in TWDView more

Year on year All Cosmos Bio-Tech Holding Corp's revenues fell -23.65%from 3.70bn to 2.83bn. In addition, the company has been unable to reduce the cost of goods sold, selling, general and administrative expenses and interest paid (all as a percentage of sales). This has contributed to a -62.15% reduction in net income from 368.20m to 139.36m.
Gross margin26.80%
Net profit margin6.46%
Operating margin6.77%
Return on assets3.90%
Return on equity4.06%
Return on investment5.92%
More ▼

Cash flow in TWDView more

In 2023, All Cosmos Bio-Tech Holding Corp increased its cash reserves by 8.75%, or 117.35m. The company earned 959.24m from its operations for a Cash Flow Margin of 33.94%. In addition the company used 202.98m on investing activities and also paid 549.88m in financing cash flows.
Cash flow per share3.07
Price/Cash flow per share17.45
Book value per share40.78
Tangible book value per share40.57
More ▼

Balance sheet in TWDView more

All Cosmos Bio-Tech Holding Corp appears to have little financial risk as the company holds a substantial amount of cash on its books. In fact, 0.41% of the market capitalization can be attributed to its 1.46bn and debt could be paid in full if management chose.
Current ratio5.51
Quick ratio3.93
Total debt/total equity0.1032
Total debt/total capital0.0761
More ▼

Growth rates in TWD

Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -60.00% and -62.30%, respectively. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)3.13%
Div growth rate (5 year)-16.06%
Payout ratio (TTM)64.02%
EPS growth(5 years)-14.82
EPS (TTM) vs
TTM 1 year ago		-47.04
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.